Camarero-Shelly M. [Vitamin B
12 levels in the patient population attending an urban health centre in Madrid].
Semergen 2017;
44:161-167. [PMID:
28457771 DOI:
10.1016/j.semerg.2017.03.006]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2016] [Revised: 12/12/2016] [Accepted: 03/08/2017] [Indexed: 10/19/2022]
Abstract
INTRODUCTION
Vitamin B12 levels are usually measured in Primary Care when the patients have symptoms or risk factors associated with its deficiency, mostly in the elderly. However, no evidence has been found to support the recommendation of screening in the general population. The aim of this study is to assess the relevance of having extended the screening of vitamin B12 deficiency to a younger population, after observing an increase in the prescription of this injected vitamin in a population under 65 years, by analysing the vitamin B12 values obtained.
MATERIAL AND METHOD
A descriptive, retrospective, observational study was conducted on a sample consisting of 5,531 patients from Barajas Health Primary Centre, Madrid, between 2008 and 2012, and on whom a blood test was performed for any reason, with values of vitamin B12.
RESULTS
A deficiency was found in 9.1% (SD 2.3) of the patients, of whom 49.4% were less than 65 years. The deficiencies were associated (P<.001, 95% CI) with age, dementia, changes in blood red cell counts, memory, and with the taking of metformin and proton pump inhibitors (P=.007).
CONCLUSION
The prevalence of vitamin B12 deficiency in our served population is similar in patients older and younger than 65 years. The extended screening was relevant.
Collapse